Works in CPT: Pharmacometrics & Systems Pharmacology, 2024, Vol 13, Issue 7

Results: 19

Correction to "Random control selection for conducting high‐throughput adverse drug events screening using large‐scale longitudinal health data".

Published in:: CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1280, doi. 10.1002/psp4.13198
Publication type:: Article

Correction to "Physiologically‐based pharmacokinetic pharmacodynamic parent‐metabolite model of edoxaban to predict drug–drug‐disease interactions: M4 contribution".

Published in:: CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1279, doi. 10.1002/psp4.13187
Publication type:: Article

Is PBPK useful to inform product label on managing clinically significant drug interactions mediated by cytokine release syndrome?

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1083, doi. 10.1002/psp4.13185

By:

Zhang, Xinyuan;
Zhao, Ping

Publication type:

Article

SAAM II: A general mathematical modeling rapid prototyping environment.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1088, doi. 10.1002/psp4.13181

By:

Perazzolo, Simone

Publication type:

Article

Population pharmacokinetics of imetelstat, a first‐in‐class oligonucleotide telomerase inhibitor.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1264, doi. 10.1002/psp4.13160

By:

González‐Sales, Mario;
Lennox, Ashley L.;
Huang, Fei;
Pamulapati, Chandra;
Wan, Ying;
Sun, Libo;
Berry, Tymara;
Kelly Behrs, Melissa;
Feller, Faye;
Morcos, Peter N.

Publication type:

Article

Quantitative systems pharmacology modeling of tumor heterogeneity in response to BH3‐mimetics using virtual tumors calibrated with cell viability assays.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1252, doi. 10.1002/psp4.13158

By:

Derippe, Thibaud;
Fouliard, Sylvain;
Decleves, Xavier;
Mager, Donald E.

Publication type:

Article

Population pharmacokinetics of adebrelimab – Support of alternative flat dose regimen in extensive‐stage small‐cell lung cancer.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1238, doi. 10.1002/psp4.13155

By:

Chen, Peng;
Zhang, Yanyan;
Wang, Yike;
Ma, Ke;
Shi, Wei;
Djebli, Nassim;
Shen, Kai

Publication type:

Article

Elucidating nonlinear pharmacokinetics of telmisartan: Integration of target‐mediated drug disposition and OATP1B3‐mediated hepatic uptake in a physiologically based model.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1224, doi. 10.1002/psp4.13154

By:

Tsuchitani, Toshiaki;
Tomaru, Atsuko;
Aoki, Yasunori;
Ishiguro, Naoki;
Tsuda, Yasuhiro;
Sugiyama, Yuichi

Publication type:

Article

A physiologically‐based pharmacokinetic precision dosing approach to manage dasatinib drug–drug interactions.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1144, doi. 10.1002/psp4.13146

By:

Kovar, Christina;
Loer, Helena Leonie Hanae;
Rüdesheim, Simeon;
Fuhr, Laura Maria;
Marok, Fatima Zahra;
Selzer, Dominik;
Schwab, Matthias;
Lehr, Thorsten

Publication type:

Article

Population pharmacokinetic analysis for dose regimen optimization of vancomycin in Southern Chinese children.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1201, doi. 10.1002/psp4.13151

By:

Shen, Xianhuan;
Li, Xuejuan;
Lu, Jieluan;
Zhu, Jiahao;
He, Yaodong;
Zhang, Zhou;
Chen, Zebin;
Zhang, Jianping;
Fan, Xiaomei;
Li, Wenzhou

Publication type:

Article

Preclinical side effect prediction through pathway engineering of protein interaction network models.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1180, doi. 10.1002/psp4.13150

By:

Alidoost, Mohammadali;
Wilson, Jennifer L.

Publication type:

Article

Navigating the landscape of parameter identifiability methods: A workflow recommendation for model development.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1170, doi. 10.1002/psp4.13148

By:

van Noort, Martijn;
Ruppert, Martijn;
DeJongh, Joost;
Marostica, Eleonora;
Bosch, Rolien;
Mešić, Emir;
Snelder, Nelleke

Publication type:

Article

Two new user‐friendly methods to assess pharmacometric parameter identifiability on categorical and continuous scales.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1160, doi. 10.1002/psp4.13147

By:

van Noort, Martijn;
Ruppert, Martijn

Publication type:

Article

Population pharmacokinetics and pharmacodynamics of nasal glucagon in patients with type 1 or 2 diabetes.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1214, doi. 10.1002/psp4.13153

By:

James, Douglas E.;
Shen, Tong;
Geiser, Jeanne S.;
Garhyan, Parag;
Chigutsa, Emmanuel

Publication type:

Article

Evaluating drug interaction potential from cytokine release syndrome using a physiologically based pharmacokinetic model: A case study of teclistamab.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1117, doi. 10.1002/psp4.13144

By:

Willemin, Marie‐Emilie;
Wang Lin, Shun Xin;
De Zwart, Loeckie;
Wu, Liviawati S.;
Miao, Xin;
Verona, Raluca;
Banerjee, Arnob;
Liu, Baolian;
Kobos, Rachel;
Qi, Ming;
Ouellet, Daniele;
Goldberg, Jenna D.;
Girgis, Suzette

Publication type:

Article

Natural disease course modeling of achondroplasia to evaluate the efficacy of recifercept in the absence of a placebo control arm in phase II study.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1103, doi. 10.1002/psp4.13143

By:

Qiao, Wenlian;
Boucher, Martin;
Slade, Alison;
Dawra, Vikas K.

Publication type:

Article

WITHDRAWAL: Quantitative modeling of approved and emerging therapeutics for modifying TTR levels in patients with Transthyretin Amyloid Cardiomyopathy.

Published in:: CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1278, doi. 10.1002/psp4.13078
Publication type:: Article

Issue Information.

Published in:: CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1079, doi. 10.1002/psp4.12990
Publication type:: Article

Joint modeling of monocyte HLA‐DR expression trajectories predicts 28‐day mortality in severe SARS‐CoV‐2 patients.

Published in:

CPT: Pharmacometrics & Systems Pharmacology, 2024, v. 13, n. 7, p. 1130, doi. 10.1002/psp4.13145

By:

Baudemont, Gaelle;
Tardivon, Coralie;
Monneret, Guillaume;
Cour, Martin;
Rimmelé, Thomas;
Garnier, Lorna;
Yonis, Hodane;
Richard, Jean‐Christophe;
Coudereau, Remy;
Gossez, Morgane;
Wallet, Florent;
Delignette, Marie‐Charlotte;
Dailler, Frederic;
Buisson, Marielle;
Lukaszewicz, Anne‐Claire;
Argaud, Laurent;
Laouenan, Cédric;
Bertrand, Julie;
Venet, Fabienne;
Pescarmona, Remi

Publication type:

Article